Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany.

The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants.

Hepatitis C-positive heart donors offer a strategy to safely expand the donor pool and allow more patients to undergo transplant.

Inhibiting COX-2 — an enzyme associated with inflammation — could provide a novel therapeutic approach for stress-related psychiatric disorders.

A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.

To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction.

VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans.